Sharp Therapeutics Corp (SHRX) Stock Price & News

All values in USD	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	-	-	-	-
Cost of goods sold	-	-	-	-
Cost of revenue	-	-	-	-
Research and development expenses	684.43K	975.47K	665.49K	665.49K
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	319.91K	589.04K	556.39K	556.39K
Operating expense	1.04M	1.72M	1.45M	1.45M
Total operating expenses	1.04M	1.72M	1.45M	1.45M
Operating income	-1.04M	-1.72M	-1.45M	-1.45M
Other non operating income	-6.86K	-632.12K	-8.58K	-8.58K
EBT including unusual items	-1.09M	-2.39M	-1.22M	-1.22M
EBT excluding unusual items	-1.09M	-2.39M	-1.50M	-1.50M
Income tax expense	-	-	-	-
Effective tax rate	-	-	-	-
Other operating expenses	-	-	-	-
Net income	-1.09M	-2.39M	-1.22M	-1.22M
Net profit margin	-	-	-	-
Earnings per share	-	-	-	-
Interest and investment income	-	82.00	16.00	16.00
Interest expense	-41.61K	-41.28K	-40.62K	-40.62K
Net interest expenses	-41.61K	-41.20K	-40.60K	-40.60K
Depreciation and amortization charges	-	-	-	-
EBITDA	-1.03M	-1.72M	-1.45M	-1.45M
Gain or loss from assets sale	-	-	-	-

Finance